InsiderSignal.AI

InsiderSignal.ai

CORT - Corcept Therapeutics Inc

Insider Sale by Guyer William (Chief Development Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Guyer William, serving as Chief Development Officer at Corcept Therapeutics Inc (CORT), sold 11,767 shares at $36.01 per share, for a total transaction value of $423,730.00. Following this transaction, Guyer William now holds 2,231 shares of CORT.

This sale represents a 84.00% decrease in Guyer William's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 20, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 24, 2026, 4 days after the trade was made.

Corcept Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Guyer William

Chief Development Officer

William Guyer, Pharm.D. is the Chief Development Officer at Corcept Therapeutics Incorporated (CORT), a position he has held since August 2021.[[1]](https://corcept.com/about/teams/william-guyer/)[[2]](https://fintool.com/app/research/companies/CORT/people/william-guyer-pharmd)[[5]](https://corcept.com/about/teams/) A clinical pharmacist with over 30 years of medical and clinical experience, Guyer previously spent nearly 20 years at Gilead Sciences, rising to Senior Vice President of Global Medical Affairs from 2015 to 2021, where he led strategies for advancing compounds from discovery to commercialization in areas such as infectious diseases, liver diseases, cancer, and inflammatory disorders, including real-world data generation and medical education programs.[[1]](https://corcept.com/about/teams/william-guyer/)[[2]](https://fintool.com/app/research/companies/CORT/people/william-guyer-pharmd) Before Gilead, he served as Director of HIV Pharmacy and Outpatient Infusion Center Services at Kaiser Permanente in Southern California.[[1]](https://corcept.com/about/teams/william-guyer/)[[2]](https://fintool.com/app/research/companies/CORT/people/william-guyer-pharmd) Guyer holds a Pharm.D. from the University of Southern California.[[1]](https://corcept.com/about/teams/william-guyer/)[[2]](https://fintool.com/app/research/companies/CORT/people/william-guyer-pharmd) As a corporate insider, he recently sold 20,000 shares of CORT on January 6, 2026, under a pre-arranged 10b5-1 trading plan, at a weighted average price of $35.18.[[3]](https://longbridge.com/en/news/272007262)[[4]](https://www.gurufocus.com/news/4103558/insider-sell-william-guyer-sells-20000-shares-of-corcept-therapeutics-inc-cort)[[6]](https://www.tradingview.com/news/tradingview:41ef6d010c853:0-corcept-therapeutics-officer-sells-shares/)[[7]](https://www.investing.com/news/insider-trading-news/guyer-corcept-therapeutics-officer-sells-703k-in-shares-93CH-4438365)

View full insider profile →

Trade Price

$36.01

Quantity

11,767

Total Value

$423,730.00

Shares Owned

2,231

Trade Date

Friday, March 20, 2026

4 days ago

SEC Filing Date

Tuesday, March 24, 2026

Filed 4 days after trade

HEALTHCAREBIOTECHNOLOGY

About Corcept Therapeutics Inc

Company Overview

No company information available
View news mentioning CORT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5060154

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime